Alan S L Yu Selected Research

claudin 8

1/2021	Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.
9/2004	Genetic heterogeneity in autosomal dominant pseudohypoaldosteronism type I: exclusion of claudin-8 as a candidate gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan S L Yu Research Topics

Disease

10	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2021 - 10/2014
5	Kidney Diseases (Kidney Disease) 01/2022 - 01/2013
4	Disease Progression 05/2021 - 11/2016
3	Cysts 01/2022 - 11/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 04/2021 - 01/2016
3	Nephrocalcinosis 01/2015 - 10/2008
2	Neoplasms (Cancer) 01/2021 - 10/2014
2	Kidney Calculi (Kidney Stone) 01/2019 - 01/2015
2	Hypercalciuria 01/2019 - 01/2015
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2018 - 10/2014
2	Hypertension (High Blood Pressure) 12/2018 - 09/2009
2	Pseudohypoaldosteronism 09/2009 - 09/2004
1	Fibrosis (Cirrhosis) 01/2022
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Headache (Headaches) 08/2020
1	Exanthema (Rash) 08/2020
1	Gastroesophageal Reflux (GERD) 08/2020
1	Nausea 08/2020
1	Diarrhea 08/2020
1	Urolithiasis 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Polycystic liver disease 11/2016
1	Hyponatremia 06/2016
1	Cognitive Dysfunction 01/2016
1	Reperfusion Injury 01/2016
1	Polyuria 03/2015
1	Hyperkalemia 09/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2009
1	Hyperaldosteronism (Conn Syndrome) 09/2004
1	Acidosis 09/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 04/2021 - 11/2016
4	CreatinineIBA 01/2022 - 01/2019
4	ClaudinsIBA 01/2021 - 10/2008
2	Fibroblast Growth Factor-23IBA 05/2021 - 04/2021
2	claudin 8IBA 01/2021 - 09/2004
2	Claudin-2IBA 01/2021 - 01/2016
2	Biological ProductsIBA 08/2020 - 10/2014
2	CalciumIBA 01/2019 - 01/2019
2	ElectrolytesIBA 01/2019 - 06/2016
2	Tolvaptan FDA Link 10/2018 - 01/2018
2	claudin 16IBA 01/2015 - 01/2013
1	Phosphates (Orthophosphate)IBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2020
1	LipidsIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2019
1	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018
1	Caffeine (No Doz)FDA LinkGeneric 12/2018
1	Pharmaceutical PreparationsIBA 10/2018
1	1-dodecylpyridoxal (PLD)IBA 11/2016
1	Protein Isoforms (Isoforms)IBA 03/2015
1	claudin 14IBA 01/2015
1	insulin receptor-related receptor (IRR)IBA 10/2014
1	Protein Kinases (Protein Kinase)IBA 09/2009
1	SaltsIBA 09/2004

Therapy/Procedure

2	Transplantation 01/2016 - 10/2014
2	Kidney Transplantation 01/2016 - 10/2014
1	Ambulatory Care (Outpatient Care) 01/2019